BioNTech to develop, produce cancer drugs in Jerusalem, says Israel’s Finance Ministry

Germany’s BioNTech SE signed a preliminary deal to set up a facility to produce cancer-related drugs and vaccines in Jerusalem, Israel’s Finance Ministry said on Tuesday.

MISSING PORCUPINE THAT DISAPPEARED FROM GERMAN ZOO FINDS ITS WAY BACK HOME

The logo of BioNTech is seen in Marburg, Germany, on Feb. 2, 2023.

Under the memorandum of understanding, BioNTech will develop the drugs and vaccines using mRNA technology in the Har Hotzvim technology park. It will also set up a research centre at the Weizmann Institute in central Israel.

Read the full article Here

Leave a Reply

Your email address will not be published. Required fields are marked *

DON’T MISS OUT!
Subscribe To Newsletter
Be the first to get latest updates and exclusive content straight to your email inbox.
Stay Updated
Give it a try, you can unsubscribe anytime.
close-link